

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 9.16384760 |
| 2 | complement activation (GO:0006956) | 8.09595407 |
| 3 | glomerular filtration (GO:0003094) | 7.48870130 |
| 4 | renal filtration (GO:0097205) | 6.74677412 |
| 5 | regulation of respiratory burst (GO:0060263) | 6.20882549 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.18529542 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.17565347 |
| 8 | protein activation cascade (GO:0072376) | 5.94617532 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.93295634 |
| 10 | antibacterial humoral response (GO:0019731) | 5.75661077 |
| 11 | antimicrobial humoral response (GO:0019730) | 5.67875198 |
| 12 | regulation of cellular extravasation (GO:0002691) | 5.32876285 |
| 13 | humoral immune response (GO:0006959) | 5.02218783 |
| 14 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.91813658 |
| 15 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.91813658 |
| 16 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.91813658 |
| 17 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.89206365 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54231527 |
| 19 | retina homeostasis (GO:0001895) | 4.09483943 |
| 20 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.07616358 |
| 21 | positive regulation of pseudopodium assembly (GO:0031274) | 4.00129733 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.96316024 |
| 23 | angiotensin maturation (GO:0002003) | 3.91505984 |
| 24 | detection of bacterium (GO:0016045) | 3.81513419 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.72511691 |
| 26 | detection of other organism (GO:0098543) | 3.70223969 |
| 27 | eosinophil chemotaxis (GO:0048245) | 3.61695381 |
| 28 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.58358735 |
| 29 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.57862935 |
| 30 | regulation of pseudopodium assembly (GO:0031272) | 3.57105803 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55328275 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.55328275 |
| 33 | regulation of antigen processing and presentation (GO:0002577) | 3.51341460 |
| 34 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.49296168 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.42862438 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.35324738 |
| 37 | type I interferon signaling pathway (GO:0060337) | 3.35324738 |
| 38 | chronic inflammatory response (GO:0002544) | 3.34452145 |
| 39 | response to type I interferon (GO:0034340) | 3.33452176 |
| 40 | eosinophil migration (GO:0072677) | 3.27609456 |
| 41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.25423619 |
| 42 | germinal center formation (GO:0002467) | 3.22967909 |
| 43 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.19774854 |
| 44 | dendritic cell chemotaxis (GO:0002407) | 3.14150875 |
| 45 | intestinal absorption (GO:0050892) | 3.12418432 |
| 46 | regulation of guanylate cyclase activity (GO:0031282) | 3.11521769 |
| 47 | cellular response to interferon-gamma (GO:0071346) | 3.06711659 |
| 48 | GDP-mannose metabolic process (GO:0019673) | 2.96610939 |
| 49 | B cell mediated immunity (GO:0019724) | 2.96552980 |
| 50 | oligosaccharide biosynthetic process (GO:0009312) | 2.92638907 |
| 51 | regulation of integrin activation (GO:0033623) | 2.91184743 |
| 52 | response to interferon-gamma (GO:0034341) | 2.88923215 |
| 53 | production of molecular mediator of immune response (GO:0002440) | 2.87715178 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83083945 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81635202 |
| 56 | regulation of vitamin metabolic process (GO:0030656) | 2.80787282 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 2.76515289 |
| 58 | detection of external biotic stimulus (GO:0098581) | 2.73611714 |
| 59 | dendritic cell migration (GO:0036336) | 2.72134308 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 2.71987259 |
| 61 | peptide catabolic process (GO:0043171) | 2.71927934 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 2.68350328 |
| 63 | virion attachment to host cell (GO:0019062) | 2.67272337 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 2.67272337 |
| 65 | T-helper 1 type immune response (GO:0042088) | 2.65803503 |
| 66 | epithelial structure maintenance (GO:0010669) | 2.65620079 |
| 67 | T cell costimulation (GO:0031295) | 2.64620811 |
| 68 | lymphocyte costimulation (GO:0031294) | 2.60668664 |
| 69 | protein-chromophore linkage (GO:0018298) | 2.59322113 |
| 70 | respiratory burst (GO:0045730) | 2.57108891 |
| 71 | negative regulation of myotube differentiation (GO:0010832) | 2.56453467 |
| 72 | regulation of necrotic cell death (GO:0010939) | 2.56083757 |
| 73 | NADH metabolic process (GO:0006734) | 2.55934672 |
| 74 | O-glycan processing (GO:0016266) | 2.51656299 |
| 75 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.48282172 |
| 76 | endocrine process (GO:0050886) | 2.48282172 |
| 77 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.48282172 |
| 78 | immune response-activating signal transduction (GO:0002757) | 2.47755363 |
| 79 | myeloid dendritic cell activation (GO:0001773) | 2.47672997 |
| 80 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.45934015 |
| 81 | arginine catabolic process (GO:0006527) | 2.45706490 |
| 82 | activation of immune response (GO:0002253) | 2.44314170 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43468520 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43216922 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.36774807 |
| 86 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.35621632 |
| 87 | positive regulation of T cell migration (GO:2000406) | 2.34343886 |
| 88 | interferon-gamma secretion (GO:0072643) | 2.32948258 |
| 89 | arginine metabolic process (GO:0006525) | 2.32590535 |
| 90 | lymph node development (GO:0048535) | 2.31876870 |
| 91 | defense response to Gram-negative bacterium (GO:0050829) | 2.31571635 |
| 92 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.30165687 |
| 93 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.30006312 |
| 94 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.28408821 |
| 95 | regulation of T cell migration (GO:2000404) | 2.27981673 |
| 96 | detection of biotic stimulus (GO:0009595) | 2.27751798 |
| 97 | regulation of regulatory T cell differentiation (GO:0045589) | 2.27124289 |
| 98 | urea cycle (GO:0000050) | 2.25476366 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.24491280 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.1898693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.13059735 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.17637987 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.09022363 |
| 4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.24713426 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05719343 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.03157785 |
| 7 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.63023697 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.58673638 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.31722594 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31655239 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08774444 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04132767 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.03305733 |
| 14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.02672846 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98898188 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89794136 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88880153 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85148829 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84517488 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76508589 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75439897 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74308093 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.73044065 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69720553 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.69596180 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.66900842 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65230257 |
| 28 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.61745533 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.60516889 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60470325 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58621283 |
| 32 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.58120789 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57058917 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55669189 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52881825 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50176836 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48821423 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.46061355 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45554793 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.44157251 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40382828 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39996310 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39544019 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39237732 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36380476 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.35799143 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.34454772 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30982143 |
| 49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28882304 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27341608 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26271041 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25558426 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24926938 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23969752 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22691614 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.21873508 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20882127 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20808156 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.18254522 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17382114 |
| 61 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16232788 |
| 62 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15331237 |
| 63 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15157843 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.15060630 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14342389 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12692146 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 1.11217801 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10035525 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09866379 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09074369 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07469999 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06981233 |
| 73 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06937878 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.06689457 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05898034 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05702466 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04925991 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04198008 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02357862 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01948531 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01533081 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00338309 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00126378 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98782344 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97633147 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96976239 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96972562 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96402268 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96241070 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95935092 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95371819 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94105337 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93321440 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91491139 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91326181 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90480866 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88851698 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86590393 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86479530 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86474203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.02592507 |
| 2 | MP0003303_peritoneal_inflammation | 3.48682669 |
| 3 | MP0010155_abnormal_intestine_physiology | 3.29911498 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.22573203 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.19852022 |
| 6 | MP0003436_decreased_susceptibility_to | 2.91706385 |
| 7 | MP0005387_immune_system_phenotype | 2.86353722 |
| 8 | MP0001790_abnormal_immune_system | 2.86353722 |
| 9 | MP0001800_abnormal_humoral_immune | 2.45263738 |
| 10 | MP0005025_abnormal_response_to | 2.42069715 |
| 11 | MP0005671_abnormal_response_to | 2.39158323 |
| 12 | MP0003866_abnormal_defecation | 2.39094967 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.37873562 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.37264843 |
| 15 | MP0005360_urolithiasis | 2.33913924 |
| 16 | MP0009785_altered_susceptibility_to | 2.30678168 |
| 17 | MP0000685_abnormal_immune_system | 2.30284272 |
| 18 | MP0001873_stomach_inflammation | 2.24946749 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.17848394 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 2.15880105 |
| 21 | MP0005166_decreased_susceptibility_to | 2.12905233 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.10909918 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.02504050 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.02492820 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.01064669 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.96071397 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.91508029 |
| 28 | MP0006082_CNS_inflammation | 1.89550403 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.89065075 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.88746684 |
| 31 | MP0001663_abnormal_digestive_system | 1.85749812 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.83214295 |
| 33 | MP0002723_abnormal_immune_serum | 1.79182708 |
| 34 | MP0002419_abnormal_innate_immunity | 1.76509085 |
| 35 | MP0001819_abnormal_immune_cell | 1.75434707 |
| 36 | MP0004858_abnormal_nervous_system | 1.74170439 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.73713747 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.73492753 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.72914189 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.68342846 |
| 41 | MP0004947_skin_inflammation | 1.61396759 |
| 42 | MP0008004_abnormal_stomach_pH | 1.57479679 |
| 43 | MP0000490_abnormal_crypts_of | 1.47053690 |
| 44 | MP0009840_abnormal_foam_cell | 1.46878992 |
| 45 | MP0002006_tumorigenesis | 1.45777237 |
| 46 | MP0005310_abnormal_salivary_gland | 1.43620422 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.43195917 |
| 48 | MP0005381_digestive/alimentary_phenotyp | 1.40232031 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.35515121 |
| 50 | MP0000477_abnormal_intestine_morphology | 1.34755839 |
| 51 | MP0003075_altered_response_to | 1.32268535 |
| 52 | MP0001664_abnormal_digestion | 1.32188694 |
| 53 | MP0005275_abnormal_skin_tensile | 1.29393673 |
| 54 | MP0002796_impaired_skin_barrier | 1.26966605 |
| 55 | MP0000716_abnormal_immune_system | 1.24031338 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.24022799 |
| 57 | MP0005365_abnormal_bile_salt | 1.19966340 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.18550260 |
| 59 | MP0004147_increased_porphyrin_level | 1.15824697 |
| 60 | MP0003045_fibrosis | 1.12942199 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.12537711 |
| 62 | MP0008469_abnormal_protein_level | 1.10577108 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.10129158 |
| 64 | MP0002398_abnormal_bone_marrow | 1.10060621 |
| 65 | MP0003448_altered_tumor_morphology | 1.09041432 |
| 66 | MP0000604_amyloidosis | 1.06541082 |
| 67 | MP0005023_abnormal_wound_healing | 1.05822824 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.03678654 |
| 69 | MP0009764_decreased_sensitivity_to | 1.02533721 |
| 70 | MP0000343_altered_response_to | 1.01932594 |
| 71 | MP0002405_respiratory_system_inflammati | 1.01098714 |
| 72 | MP0002933_joint_inflammation | 0.99308211 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.99179870 |
| 74 | MP0005451_abnormal_body_composition | 0.99060981 |
| 75 | MP0002429_abnormal_blood_cell | 0.97461530 |
| 76 | MP0003329_amyloid_beta_deposits | 0.96374750 |
| 77 | MP0000249_abnormal_blood_vessel | 0.91891404 |
| 78 | MP0005165_increased_susceptibility_to | 0.91841002 |
| 79 | MP0000858_altered_metastatic_potential | 0.90244957 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 0.89327323 |
| 81 | MP0005409_darkened_coat_color | 0.89250349 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.89201506 |
| 83 | MP0005390_skeleton_phenotype | 0.87756714 |
| 84 | MP0003868_abnormal_feces_composition | 0.87169729 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.83113913 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.81478224 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 0.80656611 |
| 88 | MP0003252_abnormal_bile_duct | 0.80198854 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.80029652 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.78990242 |
| 91 | MP0003279_aneurysm | 0.78781630 |
| 92 | MP0002722_abnormal_immune_system | 0.78682937 |
| 93 | MP0002277_abnormal_respiratory_mucosa | 0.78281262 |
| 94 | MP0004510_myositis | 0.76691864 |
| 95 | MP0005164_abnormal_response_to | 0.76332641 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.76022020 |
| 97 | MP0001851_eye_inflammation | 0.74993992 |
| 98 | MP0000678_abnormal_parathyroid_gland | 0.73735813 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 0.73560726 |
| 100 | MP0004043_abnormal_pH_regulation | 0.68118387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.41600600 |
| 2 | Malnutrition (HP:0004395) | 5.01997745 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.80066564 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.57603229 |
| 5 | Prostate neoplasm (HP:0100787) | 4.25467055 |
| 6 | Abnormality of complement system (HP:0005339) | 4.00326703 |
| 7 | Glomerulonephritis (HP:0000099) | 4.00322153 |
| 8 | Vasculitis (HP:0002633) | 3.88686306 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.71839547 |
| 10 | Complement deficiency (HP:0004431) | 3.63443544 |
| 11 | Gastrointestinal stroma tumor (HP:0100723) | 3.61734809 |
| 12 | Hyperactive renin-angiotensin system (HP:0000841) | 3.45560764 |
| 13 | Agammaglobulinemia (HP:0004432) | 3.39411517 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.35167875 |
| 15 | Nephritis (HP:0000123) | 3.30379105 |
| 16 | Abnormality of the prostate (HP:0008775) | 3.23232016 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.17719056 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.14923986 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.13557497 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11965425 |
| 21 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.09292273 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.07823506 |
| 23 | Meningitis (HP:0001287) | 3.07517954 |
| 24 | Chronic diarrhea (HP:0002028) | 3.06476967 |
| 25 | Colitis (HP:0002583) | 2.96044395 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 2.94835707 |
| 27 | Cellulitis (HP:0100658) | 2.93691861 |
| 28 | Increased IgE level (HP:0003212) | 2.91172209 |
| 29 | Premature loss of primary teeth (HP:0006323) | 2.91085059 |
| 30 | Skin rash (HP:0000988) | 2.85631240 |
| 31 | Osteomyelitis (HP:0002754) | 2.80145364 |
| 32 | Myositis (HP:0100614) | 2.78421273 |
| 33 | Emphysema (HP:0002097) | 2.77776937 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.75803209 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.75628415 |
| 36 | Urticaria (HP:0001025) | 2.75006609 |
| 37 | Orchitis (HP:0100796) | 2.73903909 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.72459570 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71342528 |
| 40 | Chronic otitis media (HP:0000389) | 2.71124756 |
| 41 | Metabolic alkalosis (HP:0200114) | 2.67106773 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.64477397 |
| 43 | Obstructive lung disease (HP:0006536) | 2.62639194 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62639194 |
| 45 | Gingivitis (HP:0000230) | 2.59160107 |
| 46 | Alkalosis (HP:0001948) | 2.59001274 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.58803231 |
| 48 | Ileus (HP:0002595) | 2.58300365 |
| 49 | Hemoptysis (HP:0002105) | 2.57881068 |
| 50 | Leukocytosis (HP:0001974) | 2.57750775 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57644465 |
| 52 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.48261828 |
| 53 | Villous atrophy (HP:0011473) | 2.48261828 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.46855697 |
| 55 | Right ventricular cardiomyopathy (HP:0011663) | 2.44047644 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.42380323 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.39822305 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.39021669 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 2.38600915 |
| 60 | Recurrent viral infections (HP:0004429) | 2.38065000 |
| 61 | Recurrent sinusitis (HP:0011108) | 2.27967124 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.26453138 |
| 63 | Pustule (HP:0200039) | 2.26139283 |
| 64 | Recurrent skin infections (HP:0001581) | 2.25713868 |
| 65 | Retrobulbar optic neuritis (HP:0100654) | 2.22981306 |
| 66 | Optic neuritis (HP:0100653) | 2.22981306 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.21480460 |
| 68 | Restrictive lung disease (HP:0002091) | 2.20429998 |
| 69 | Flat acetabular roof (HP:0003180) | 2.19433870 |
| 70 | Increased IgM level (HP:0003496) | 2.19063824 |
| 71 | Nasal polyposis (HP:0100582) | 2.18232183 |
| 72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.11376394 |
| 73 | Lymphopenia (HP:0001888) | 2.11206021 |
| 74 | Bronchitis (HP:0012387) | 2.10565504 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.05495776 |
| 76 | Purpura (HP:0000979) | 2.03071489 |
| 77 | Polycythemia (HP:0001901) | 2.00283484 |
| 78 | Neoplasm of the lung (HP:0100526) | 1.98589077 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 1.97923907 |
| 80 | Chest pain (HP:0100749) | 1.96599544 |
| 81 | Skin ulcer (HP:0200042) | 1.95956520 |
| 82 | Hydroxyprolinuria (HP:0003080) | 1.95629268 |
| 83 | Abnormality of proline metabolism (HP:0010907) | 1.95629268 |
| 84 | Chronic sinusitis (HP:0011109) | 1.95149292 |
| 85 | Hematochezia (HP:0002573) | 1.94732287 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94573431 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94573431 |
| 88 | B lymphocytopenia (HP:0010976) | 1.94065701 |
| 89 | Papilloma (HP:0012740) | 1.93809270 |
| 90 | Verrucae (HP:0200043) | 1.93809270 |
| 91 | Congenital sensorineural hearing impairment (HP:0008527) | 1.93205756 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 1.92470596 |
| 93 | Abnormality of male internal genitalia (HP:0000022) | 1.91547555 |
| 94 | Encephalitis (HP:0002383) | 1.88726401 |
| 95 | Abnormality of the pleura (HP:0002103) | 1.84963306 |
| 96 | Ventricular fibrillation (HP:0001663) | 1.84907178 |
| 97 | Sepsis (HP:0100806) | 1.84058388 |
| 98 | Keratoconjunctivitis sicca (HP:0001097) | 1.83534608 |
| 99 | Fat malabsorption (HP:0002630) | 1.82744925 |
| 100 | Cheilitis (HP:0100825) | 1.81681965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.55576553 |
| 2 | MST1R | 3.43093675 |
| 3 | TYK2 | 3.27686055 |
| 4 | MAP4K1 | 3.24853533 |
| 5 | RIPK4 | 2.98119970 |
| 6 | FGFR4 | 2.79751630 |
| 7 | RIPK1 | 2.59839615 |
| 8 | PRPF4B | 2.59343268 |
| 9 | ACVR1B | 2.05330678 |
| 10 | EPHA3 | 2.04688390 |
| 11 | EPHB1 | 1.95849756 |
| 12 | BLK | 1.94762183 |
| 13 | KIT | 1.92926337 |
| 14 | JAK3 | 1.79238247 |
| 15 | JAK1 | 1.76030735 |
| 16 | GRK6 | 1.73740677 |
| 17 | CDC42BPA | 1.70365404 |
| 18 | PIK3CA | 1.64091121 |
| 19 | CSK | 1.62705253 |
| 20 | IRAK4 | 1.60336863 |
| 21 | EPHA2 | 1.55621627 |
| 22 | ZAP70 | 1.54723698 |
| 23 | PRKG2 | 1.54596870 |
| 24 | IKBKE | 1.52205786 |
| 25 | FGFR3 | 1.51285611 |
| 26 | TBK1 | 1.50662008 |
| 27 | MATK | 1.46853967 |
| 28 | FES | 1.35772699 |
| 29 | EPHB2 | 1.35132325 |
| 30 | MAP3K10 | 1.33092635 |
| 31 | MAP3K1 | 1.32354297 |
| 32 | MAP3K14 | 1.31389431 |
| 33 | SYK | 1.31041232 |
| 34 | DDR2 | 1.30437191 |
| 35 | PTK6 | 1.23820294 |
| 36 | JAK2 | 1.20811518 |
| 37 | STK39 | 1.16998040 |
| 38 | LYN | 1.15410359 |
| 39 | TXK | 1.15158740 |
| 40 | OXSR1 | 1.13747618 |
| 41 | TGFBR2 | 1.12989685 |
| 42 | MAP3K3 | 1.10921219 |
| 43 | TAOK1 | 1.10838744 |
| 44 | CDK19 | 1.09527295 |
| 45 | SMG1 | 1.08942468 |
| 46 | IRAK1 | 1.06950803 |
| 47 | STK24 | 1.03942836 |
| 48 | BMPR2 | 1.02536819 |
| 49 | BTK | 1.01536615 |
| 50 | SIK3 | 0.96407365 |
| 51 | PDGFRA | 0.95779879 |
| 52 | MET | 0.94831242 |
| 53 | MAP2K3 | 0.94662329 |
| 54 | FER | 0.94171091 |
| 55 | CSF1R | 0.91870143 |
| 56 | TRIB3 | 0.91808756 |
| 57 | HCK | 0.90529942 |
| 58 | LMTK2 | 0.86644838 |
| 59 | TAOK3 | 0.80953257 |
| 60 | NLK | 0.73733638 |
| 61 | FGR | 0.72513890 |
| 62 | PDPK1 | 0.71513677 |
| 63 | MYLK | 0.70443031 |
| 64 | PKN2 | 0.68337464 |
| 65 | LCK | 0.68329471 |
| 66 | TESK2 | 0.67527992 |
| 67 | MAP3K11 | 0.67284692 |
| 68 | IRAK3 | 0.66646963 |
| 69 | IKBKB | 0.65220332 |
| 70 | MAP3K2 | 0.63439063 |
| 71 | YES1 | 0.62527166 |
| 72 | MAPK7 | 0.61248314 |
| 73 | ITK | 0.61062683 |
| 74 | PAK4 | 0.60532037 |
| 75 | HIPK2 | 0.56906551 |
| 76 | MAPK11 | 0.56886865 |
| 77 | PDK1 | 0.55634214 |
| 78 | KSR2 | 0.54891360 |
| 79 | LRRK2 | 0.52451875 |
| 80 | PDGFRB | 0.52368150 |
| 81 | TAOK2 | 0.52365490 |
| 82 | FYN | 0.52272779 |
| 83 | MAP2K2 | 0.51574744 |
| 84 | MAP3K13 | 0.50743057 |
| 85 | RET | 0.48992498 |
| 86 | MAP2K6 | 0.48581849 |
| 87 | MAPKAPK2 | 0.47469893 |
| 88 | NEK9 | 0.42982043 |
| 89 | GRK5 | 0.41506749 |
| 90 | TEC | 0.39403081 |
| 91 | GRK1 | 0.38885617 |
| 92 | MAP3K12 | 0.38852478 |
| 93 | MAP3K6 | 0.38278461 |
| 94 | PRKCD | 0.37956384 |
| 95 | CDK6 | 0.35910034 |
| 96 | PRKCQ | 0.35853286 |
| 97 | BMX | 0.33781824 |
| 98 | SRC | 0.33713581 |
| 99 | IGF1R | 0.33340194 |
| 100 | TNK2 | 0.30435702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.93121102 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.61779250 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.45246341 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.43896583 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.27179588 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22107563 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.99591308 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.61977582 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38712150 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22800893 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05513904 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.99013262 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96755408 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95311029 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84355458 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.72471925 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68692786 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61926559 |
| 19 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.49460490 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.48467887 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43444547 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42542871 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32261546 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.27610337 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.27383084 |
| 26 | Mineral absorption_Homo sapiens_hsa04978 | 1.26027495 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25183013 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.20673487 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20104608 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18678109 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14206881 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11994266 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08613934 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06627468 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05718830 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04605693 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03929084 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99225746 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 0.96380416 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95134631 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90614460 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90205774 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89298120 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88901132 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88358907 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87576168 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85767006 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85130515 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.83669827 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83519897 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83485008 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83272113 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.82474992 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78522521 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75403476 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72181342 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72026707 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72020056 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70459572 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69137668 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68351843 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67719433 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66333502 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63424930 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62967383 |
| 66 | Measles_Homo sapiens_hsa05162 | 0.56666725 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55192350 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53559939 |
| 69 | Amoebiasis_Homo sapiens_hsa05146 | 0.53044253 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52378781 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50123811 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48221262 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47330182 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46467742 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46168888 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45009595 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44425950 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.43952062 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43687647 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41610494 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.40114690 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.38490728 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37939553 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37376126 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37350941 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.37249891 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36178735 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35397572 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34611817 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33173931 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32147239 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30071996 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29954002 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29736467 |
| 95 | Legionellosis_Homo sapiens_hsa05134 | 0.29199145 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28795117 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27886450 |
| 98 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.25605828 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24863058 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24567471 |

